HIGHLIGHTS
- who: Kiran Kumar Naidu Guturi from the results, we have established that -catenin when phosphorylated at Ser, is a key factor in promoting EGFR expression and EGFR-dependent proliferation and survivalAll of these results strongly suggest that activation of -catenin signaling may be associated with the progression of the disease through signaling cross-talk. Thus, our study can open a new in the combinatorial therapeutic approach which is currently under development in cancer treatment (42, , ). Acknowledgments-We thank Dr. K. M. Yamada (Chief, Laboratory of Cell and Developmental Biology, National Institute of Health/ NIDCR) and Dr. B . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.